NYSEARCA:STXS - NYSE Arca - US85916J4094 - Common Stock - Currency: USD
2.19
-0.1 (-4.37%)
The current stock price of STXS is 2.19 USD. In the past month the price decreased by -0.9%. In the past year, price decreased by -28.2%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 122 full-time employees. The company went IPO on 2004-08-12. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
STEREOTAXIS INC
710 N Tucker Blvd, Ste 110
St. Louis MISSOURI 63108 US
CEO: David L. Fischel
Employees: 122
Company Website: https://www.stereotaxis.com/
Investor Relations: https://ir.stereotaxis.com
Phone: 13146786100
The current stock price of STXS is 2.19 USD. The price decreased by -4.37% in the last trading session.
The exchange symbol of STEREOTAXIS INC is STXS and it is listed on the NYSE Arca exchange.
STXS stock is listed on the NYSE Arca exchange.
10 analysts have analysed STXS and the average price target is 4.59 USD. This implies a price increase of 109.59% is expected in the next year compared to the current price of 2.19. Check the STEREOTAXIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
STEREOTAXIS INC (STXS) has a market capitalization of 185.56M USD. This makes STXS a Micro Cap stock.
STEREOTAXIS INC (STXS) currently has 122 employees.
STEREOTAXIS INC (STXS) has a support level at 2.19 and a resistance level at 2.28. Check the full technical report for a detailed analysis of STXS support and resistance levels.
The Revenue of STEREOTAXIS INC (STXS) is expected to decline by -8.94% in the next year. Check the estimates tab for more information on the STXS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
STXS does not pay a dividend.
STEREOTAXIS INC (STXS) will report earnings on 2025-03-03, after the market close.
STEREOTAXIS INC (STXS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).
The outstanding short interest for STEREOTAXIS INC (STXS) is 4.59% of its float. Check the ownership tab for more information on the STXS short interest.
ChartMill assigns a technical rating of 2 / 10 to STXS. When comparing the yearly performance of all stocks, STXS is a bad performer in the overall market: 77.77% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to STXS. STXS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months STXS reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS decreased by -3.7% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -44.95% | ||
ROE | -141.11% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 82% to STXS. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 2.55% and a revenue growth -8.94% for STXS